The nonprofit is focused on access to precision medicine testing and treatment for former special operations forces personnel ...
MD Anderson Researchers Secure Grant to Test Cell Therapy in Melanoma Patients With Brain Metastasis
With $1.6 million from CPRIT, investigators are testing an endogenous T-cell therapy that has certain advantages over CAR ...
Doctors can use the test, developed by Endeavor Health in collaboration with GenomicMD, to direct more aggressive treatment ...
The FDA recently removed non-ambulatory Duchenne patients from the gene therapy's indication, which Sarepta hopes to have reinstated.
From 2017 until Oct. 1, 2025, sponsors have submitted around 50 INDs seeking to begin clinical testing of individualized ...
NEW YORK – Fifteen drugs will be offered at a lower cost under Medicare Part D beginning in 2027 after the latest round of drug price negotiations between pharma companies and the Centers for Medicare ...
NEW YORK – The UK's National Institute for Health and Care Excellence has recommended Aucatzyl (obecabtagene autoleucel), a CAR T-cell therapy developed by Autolus Therapeutics, for routine use within ...
This article has been updated to reflect EU label data on the sustained clinical benefit of Breyanzi. NEW YORK – The European Commission on Monday approved Bristol Myers Squibb's CAR T-cell therapy ...
NEW YORK – The National Society of Genetic Counselors last week re-introduced a bill that would allow its members to bill Medicare. US Reps. Adrian Smith, R-Neb., and Kathy Castor, D-Fla., introduced ...
This article has been updated to add information from Novartis about the price of Itvisma. NEW YORK – The US Food and Drug Administration on Monday approved a new, injectable spinal muscular atrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback